No Detail Found!

Assessing the diagnostic precision of chosen equational scores in detecting steatosis through elastography

Author(s)
Sajid Alhaidari Department of Biochemistry,Faculty of Medicine of Sousse,4002 Sousse , Tunisia
B Charfeddine Department of Biochemistry,Faculty of Medicine of Sousse,4002 Sousse , Tunisia
Talal Hadi Basrah Hospital of Gastroenterology, Basrah Health Directorate, Basrah ,Iraq
Abstract
Background: Several non-interventional imaging studies, scoring systems, and biochemical markers are widely used nowadays to urgently diagnose stage and manage cases of non-alcoholic fatty liver disease (NAFLD) to avoid potential complications. The current study aimed to compare the sensitivity, specificity, and positive predictive values (PPR) of some widely used NAFLD-induced steatosis scoring systems.Methods: Fifty patients confirmed with fatty liver by ultrasonography were recruited in this study. All patients underwent steatosis staging using FibroScan. For all patients, aspartate transaminase (AST), alanine transaminase (ALT), platelet count, and body mass index were measured for the calculation of aspartate transaminase to platelet ratio index (APRI), hepatic steatosis index (HSI), and AST/ALT equations. Sensitivity, specificity, and PPR for the three scoring systems were calculated compared to FibroScan scoring results as the standard validating system where S0 and S1 scores were considered negative while S2 and S3 scores were considered positive for hepatic steatosis. Results: Sensitivity results were 45, 87.8, and 45.9%; specificity results were 30, 22.2, and 69.2%; and PPR results were 72, 83.7, and 82.9% for APRI, HSI, and AST/ALT ratio scoring equation, respectively. Conclusion: Among the three steatosis scoring systems studied in the present study, the HSI was the most sensitive scoring system, and the AST/ALT ratio was the most specific scoring system compared to the FibroScan as the standard steatosis scoring system.
Publication Details
Page(s) 455-461
DOI DOI not available
Published Journal: Advancements in life sciences, Volume: 11, Issue: 2, Year: 2024

Request the full text from PASTIC

Keywords
Equational Scores, Steatosis Elastography, AST/ALTAPRI
References
Mikolasevic I MS,Wensveen TT,Grgic I,Jakopcic I,Stimac D .2016 .Nonalcoholic fatty liver disease - A multisystem disease. World Journal Gastroenterology, 22(43) : 9488-9505.
Darvishi M AK,Toama MA,Hadrawi SK,Ramadan MF,Pirhadi M .2023 .A Review of the Effects of Omega-3 and Omega-6 on Alcoholic and Non-Alcoholic Fatty Liver. , 10(4) : 530-536.
Çiftçioğlu M KB,Ispiroğlu M .2023 .Gişi K. Frequency of fibrosis in patients with incidentally detected hepatosteatosis. Revista da Associação Médica Brasileira, 70(1) : 1-5.
Waseem M SF,Khan R .2022 .Ultrasound Detected Non-Alcoholic Fatty Liver Disease Prevalence and its Risk Factors in Pakistani Population. , 9(4) : 607-611.
Joseph AE SS,al-Sam S,Cook MG,Maxwell JD .1991 .Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clinical radiology, 43(1) : 26-31.
Dasarathy S DJ,Khiyami A,Joseph R,Lopez R,McCullough AJ .2009 .Validity of real-time ultrasound in the diagnosis of hepatic steatosis: a prospective study. Journal of hepatology, 51(6) : 1061-1067.
Shiralkar K JS,Bluth EI,Marshall RH,Dornelles A,Gulotta PM .2015 .Improved method for calculating hepatic steatosis using the hepatorenal index. Journal of Ultrasound in Medicine, 34(6) : 1051-1059.
Ballestri S LA,Romagnoli D,Carulli L,Losi L,Day CP .2012 .Ultrasonographic fatty liver indicator, a novel score that rules out NASH and is correlated with metabolic parameters in NAFLD. , 32(8) : 1242-1252.
Chan WK NMN,Mahadeva S. .2014 .Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease. Journal of gastroenterology and hepatology, 29(7) : 1470-1476.
Sasso M BM,de Ledinghen V,Douvin C,Marcellin P,Poupon R .2010 .Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound in medicine & biology, 36(11) : 1825-1835.
Lau Liu K WV,Liu K,Tse SD,Yip YK,TC YK .2017 .Prognostic Value of Controlled Attenuation Parameter by Transient Elastography. Official journal of the American College of Gastroenterology| ACG, 112(12) : 1812-1823.
De Matteis C CM ,Graziano G,Battaglia S,Suppressa P,Piazzolla G .2021 .AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects. Scientific Reports, 11(1) : 1-14.
. .Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes.. , : .
.2018 .. Journal of gastroenterology and hepatology, 33(1) : 270-276.
.2010 .. Journal of hepatology, 52(4) : 579-585.
.2022 .. Annals of Hepatology, 27(2) : 1-6.
Tovo C V. V-NC ,Leite NC,Panke CL,Port GZ,Fernandes S .2019 .Transient hepatic elastography has the best performance in evaluating liver fibrosis in non-alcoholic fatty liver disease (NAFLD). Annals of hepatology, 18(3) : 445-449.
Vuppalanchi R ÜA ML,Cummings OW,Sandrasegaran KE,Hameed T .2009 .. Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology, 7(4) : 481-486.
.2023 .Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis. Annals of Hepatology, 28(1) : 1-10.
Lavine Chalasani N YZ,Charlton JE,Cusi M,Rinella K,M K .2018 .The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. , 67(1) : 328-357.
.2020 .Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. , : .
Hepatology Research .2021 .. , 51(10) : 1013-1025.
HY. K. .2021 .Recent advances in nonalcoholic fatty liver disease metabolomics. Clinical and molecular hepatology, 27(4) : 553-559.
Krznaric-Zrnic Mikolasevic I DV,Krznaric I,Virovic-Jukic Z,Stojsavljevic L,Grgurevic S,Milic I,Vukoja S,Puz I,Aralica P,Hauser M,G. M .2022 .The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy. , 58(2) : 1-14.
Kim Chung J PH,Yu YJ,Park MH,Jung S,SI S .2021 .Association of Hepatic Steatosis Index with Nonalcoholic Fatty Liver Disease Diagnosed by Non-Enhanced CT in a Screening Population. Diagnostics (Basel), 11(12) : .
.2022 .Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches. , 12(2) : 1-11.
. .To read a copy of this license please visit: https://creativecommons. , : .
0

Citations

0

Downloads

45

Views